Artykuły w czasopismach na temat „Dox-Induced Cardiotoxicity”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Dox-Induced Cardiotoxicity”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Sumneang, Natticha, Pongpan Tanajak i Thura Tun Oo. "Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity". Molecules 28, nr 11 (24.05.2023): 4294. http://dx.doi.org/10.3390/molecules28114294.
Pełny tekst źródłaAmmar, El-Sayed M., Shehta A. Said, Ghada M. Suddek i Sally L. El-Damarawy. "Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats". Canadian Journal of Physiology and Pharmacology 89, nr 4 (kwiecień 2011): 269–76. http://dx.doi.org/10.1139/y11-020.
Pełny tekst źródłaHamaamin, Karmand Salih, i Tavga Ahmed Aziz. "Doxorubicin-Induced Cardiotoxicity: Mechanisms and Management". Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ) 3 (10.12.2022): 87–97. http://dx.doi.org/10.54133/ajms.v3i.90.
Pełny tekst źródłaZheng, Dong, Yi Zhang, Ming Zheng, Ting Cao, Grace Wang, Lulu Zhang, Rui Ni i in. "Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity". Clinical Science 133, nr 13 (lipiec 2019): 1505–21. http://dx.doi.org/10.1042/cs20181022.
Pełny tekst źródłaZhang, Wei, Zhixing Fan, Fengyuan Wang, Lin Yin, Jinchun Wu, Dengke Li, Siwei Song, Xi Wang, Yanhong Tang i Congxin Huang. "Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3". Oxidative Medicine and Cellular Longevity 2023 (14.01.2023): 1–23. http://dx.doi.org/10.1155/2023/9966355.
Pełny tekst źródłaMao, Jin Ning, Ai Jun Li, Liang Ping Zhao, Lan Gao, Wei Ting Xu, Xiao Su Hong, Wen Ping Jiang i Jian Chang Chen. "PEG-PLGA Nanoparticles Entrapping Doxorubicin Reduced Doxorubicin-Induced Cardiotoxicity in Rats". Advanced Materials Research 912-914 (kwiecień 2014): 263–68. http://dx.doi.org/10.4028/www.scientific.net/amr.912-914.263.
Pełny tekst źródłaManeechote, Chayodom, Siriporn C. Chattipakorn i Nipon Chattipakorn. "Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity". Pharmaceutics 15, nr 4 (7.04.2023): 1182. http://dx.doi.org/10.3390/pharmaceutics15041182.
Pełny tekst źródłaKitakata, Hiroki, Jin Endo, Hidehiko Ikura, Hidenori Moriyama, Kohsuke Shirakawa, Yoshinori Katsumata i Motoaki Sano. "Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis". International Journal of Molecular Sciences 23, nr 3 (26.01.2022): 1414. http://dx.doi.org/10.3390/ijms23031414.
Pełny tekst źródłada Cunha Menezes Souza, Leonardo, Meng Chen, Yuji Ikeno, Daisy Maria Fávero Salvadori i Yidong Bai. "The implications of mitochondria in doxorubicin treatment of cancer in the context of traditional and modern medicine". Traditional Medicine and Modern Medicine 03, nr 04 (grudzień 2020): 239–54. http://dx.doi.org/10.1142/s2575900020300076.
Pełny tekst źródłaJiang, Lai, Yanping Gong, Yida Hu, Yangyang You, Jiawu Wang, Zhetao Zhang, Zeyuan Wei i Chaoliang Tang. "Peroxiredoxin-1 Overexpression Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and Cardiomyocyte Apoptosis". Oxidative Medicine and Cellular Longevity 2020 (29.07.2020): 1–11. http://dx.doi.org/10.1155/2020/2405135.
Pełny tekst źródłaCheng, Xiaoli, Dan Liu, Ruinan Xing, Haixu Song, Xiaoxiang Tian, Chenghui Yan i Yaling Han. "Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling". BioMed Research International 2020 (19.10.2020): 1–13. http://dx.doi.org/10.1155/2020/5923572.
Pełny tekst źródłaMiranda, Carlos J., Hortence Makui, Ricardo J. Soares, Marc Bilodeau, Jeannie Mui, Hajatollah Vali, Richard Bertrand, Nancy C. Andrews i Manuela M. Santos. "Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin". Blood 102, nr 7 (1.10.2003): 2574–80. http://dx.doi.org/10.1182/blood-2003-03-0869.
Pełny tekst źródłaJiao, Yuheng, Yanyan Li, Jiayan Zhang, Song Zhang, Yafang Zha i Jian Wang. "RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway". Biomolecules 12, nr 2 (12.02.2022): 299. http://dx.doi.org/10.3390/biom12020299.
Pełny tekst źródłaHu, Xiaoping, Huagang Liu, Zhiwei Wang, Zhipeng Hu i Luocheng Li. "miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice". Oxidative Medicine and Cellular Longevity 2019 (3.11.2019): 1–13. http://dx.doi.org/10.1155/2019/1512326.
Pełny tekst źródłaBhagat, Anchit, i Eugenie S. Kleinerman. "Neutrophils contribute to Doxorubicin-Induced Cardiotoxicity". Journal of Immunology 206, nr 1_Supplement (1.05.2021): 111.23. http://dx.doi.org/10.4049/jimmunol.206.supp.111.23.
Pełny tekst źródłaYu, Yangsheng, Degang Guo i Lin Zhao. "MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b". Evidence-Based Complementary and Alternative Medicine 2022 (15.07.2022): 1–13. http://dx.doi.org/10.1155/2022/4364779.
Pełny tekst źródłaMao, Meijiao, Wang Zheng, Bin Deng, Youhua Wang, Duan Zhou, Lin Shen, Wankang Niku i Na Zhang. "Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes". PLOS ONE 18, nr 10 (12.10.2023): e0292124. http://dx.doi.org/10.1371/journal.pone.0292124.
Pełny tekst źródłaZhao, Yintao, Jingjing Sun, Wei Zhang, Meng Peng, Jun Chen, Lu Zheng, Xiangqin Zhang, Haibo Yang i Yuan Liu. "Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2". Oxidative Medicine and Cellular Longevity 2020 (3.08.2020): 1–11. http://dx.doi.org/10.1155/2020/3598715.
Pełny tekst źródłaWang, Tao, Chuqiao Yuan, Jia Liu, Liangyan Deng, Wei Li, Junling He, Honglin Liu, Liping Qu, Jianming Wu i Wenjun Zou. "Targeting Energy Protection as a Novel Strategy to Disclose Di’ao Xinxuekang against the Cardiotoxicity Caused by Doxorubicin". International Journal of Molecular Sciences 24, nr 2 (4.01.2023): 897. http://dx.doi.org/10.3390/ijms24020897.
Pełny tekst źródłaWang, Jingya, Lin Yao, Xiaoli Wu, Qi Guo, Shengxuan Sun, Jie Li, Guoqi Shi, Ruth B. Caldwell, R. William Caldwell i Yongjun Chen. "Protection against Doxorubicin-Induced Cardiotoxicity through Modulating iNOS/ARG 2 Balance by Electroacupuncture at PC6". Oxidative Medicine and Cellular Longevity 2021 (20.03.2021): 1–17. http://dx.doi.org/10.1155/2021/6628957.
Pełny tekst źródłaLue, Yanhe, Chen Gao, Ronald Swerdloff, James Hoang, Rozeta Avetisyan, Yue Jia, Meng Rao i in. "Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity". American Journal of Physiology-Heart and Circulatory Physiology 315, nr 3 (1.09.2018): H634—H643. http://dx.doi.org/10.1152/ajpheart.00155.2018.
Pełny tekst źródłaLi, Jing, Huiping Liu, Srinivasan Ramachandran, Gregory B. Waypa, Jun-Jie Yin, Chang-Qing Li, Mei Han i in. "Grape Seed Proanthocyanidins Ameliorate Doxorubicin-Induced Cardiotoxicity". American Journal of Chinese Medicine 38, nr 03 (styczeń 2010): 569–84. http://dx.doi.org/10.1142/s0192415x10008068.
Pełny tekst źródłaSmuder, Ashley J., Andreas N. Kavazis, Kisuk Min i Scott K. Powers. "Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals". Journal of Applied Physiology 115, nr 2 (15.07.2013): 176–85. http://dx.doi.org/10.1152/japplphysiol.00924.2012.
Pełny tekst źródłaAshour, Abdelkader E., Mohamed M. Sayed-Ahmed, Adel R. Abd-Allah, Hesham M. Korashy, Zaid H. Maayah, Hisham Alkhalidi, Mohammed Mubarak i Abdulqader Alhaider. "Metformin Rescues the Myocardium from Doxorubicin-Induced Energy Starvation and Mitochondrial Damage in Rats". Oxidative Medicine and Cellular Longevity 2012 (2012): 1–13. http://dx.doi.org/10.1155/2012/434195.
Pełny tekst źródłaLi, Ling-Li, Li Wei, Ning Zhang, Wen-Ying Wei, Can Hu, Wei Deng i Qi-Zhu Tang. "Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway". BioMed Research International 2020 (8.06.2020): 1–11. http://dx.doi.org/10.1155/2020/8593617.
Pełny tekst źródłaLi, Siying, Wenjuan Wang, Ting Niu, Hui Wang, Bin Li, Lei Shao, Yimu Lai i in. "Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction". Oxidative Medicine and Cellular Longevity 2014 (2014): 1–15. http://dx.doi.org/10.1155/2014/748524.
Pełny tekst źródłaHaesen, Sibren, Manon Marie Jager, Aline Brillouet, Iris de Laat, Lotte Vastmans, Eline Verghote, Anouk Delaet i in. "Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity". Antioxidants 13, nr 1 (17.01.2024): 112. http://dx.doi.org/10.3390/antiox13010112.
Pełny tekst źródłaShan, Lingling, Yulong Huo, Siyu Li, Wanrong Li, Jing Wang, Yang Yang, Langzi Wang i Lin Chen. "Geraniin-Based Self-Assemble Nanoplatform for Antioxidation Reduced Cardiotoxicity and Tumor Synergistic Therapy". Journal of Biomedical Nanotechnology 19, nr 5 (1.05.2023): 758–69. http://dx.doi.org/10.1166/jbn.2023.3580.
Pełny tekst źródłaOno, Masaya, Yoichi Sunagawa, Saho Mochizuki, Takahiro Katagiri, Hidemichi Takai, Sonoka Iwashimizu, Kyoko Inai i in. "Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis". Cancers 14, nr 3 (28.01.2022): 683. http://dx.doi.org/10.3390/cancers14030683.
Pełny tekst źródłaJiang, Yu, Yanjuan Liu, Wen Xiao, Dandan Zhang, Xiehong Liu, Huiqiong Xiao, Sanli You i Lili Yuan. "Xinmailong Attenuates Doxorubicin-Induced Lysosomal Dysfunction and Oxidative Stress in H9c2 Cells via HO-1". Oxidative Medicine and Cellular Longevity 2021 (27.03.2021): 1–11. http://dx.doi.org/10.1155/2021/5896931.
Pełny tekst źródłaTaylor, Justin R., i Kyra Harames. "Abstract 4771: Prevention of doxorubicin-induced cardiotoxicity by benfotiamine". Cancer Research 83, nr 7_Supplement (4.04.2023): 4771. http://dx.doi.org/10.1158/1538-7445.am2023-4771.
Pełny tekst źródłaKoczurkiewicz-Adamczyk, Paulina, Katarzyna Klaś, Agnieszka Gunia-Krzyżak, Kamil Piska, Kalina Andrysiak, Jacek Stępniewski, Sławomir Lasota i in. "Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin". International Journal of Molecular Sciences 22, nr 12 (9.06.2021): 6217. http://dx.doi.org/10.3390/ijms22126217.
Pełny tekst źródłaLiu, Yuzhou, Liying Zhou, Binbin Du, Yuan Liu, Junhui Xing, Sen Guo, Ling Li i Hongrui Chen. "Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway". Oxidative Medicine and Cellular Longevity 2021 (6.08.2021): 1–18. http://dx.doi.org/10.1155/2021/9984330.
Pełny tekst źródłaLee, Eun Ji, Woong Bi Jang, Jaewoo Choi, Hye Ji Lim, Sangmi Park, Vinoth Kumar Rethineswaran, Jong Seong Ha i in. "The Protective Role of Glutathione against Doxorubicin-Induced Cardiotoxicity in Human Cardiac Progenitor Cells". International Journal of Molecular Sciences 24, nr 15 (28.07.2023): 12070. http://dx.doi.org/10.3390/ijms241512070.
Pełny tekst źródłaEgwuatu, Ifeanyi Anthony, Chiadikobi Lawrence Ozoemena, Emeka Williams Ugwuishi, Christian Chiemeka Ozor, Augustine Oviosun i Favour Onwene. "Deciphering the Ameliorative Potential of 5, 7-dihydroxyflavone (Chrysin) on Doxorubicin-Induced Cardiotoxicity by Modulating Oxidative Stress in Rats". Scholars International Journal of Anatomy and Physiology 6, nr 11 (23.11.2023): 181–90. http://dx.doi.org/10.36348/sijap.2023.v06i11.005.
Pełny tekst źródłaAbdul Karim, Lubna Zuhair, Inam Sameh Arif i Fouad A. Al Saady. "Lipidomics application to explain acute cardiotoxicity induced by doxorubicin". Al Mustansiriyah Journal of Pharmaceutical Sciences 19, nr 4 (1.12.2019): 161–69. http://dx.doi.org/10.32947/ajps.v19i4.647.
Pełny tekst źródłaChen, Sida, Yang Huang, Suiqing Huang, Zhuoming Zhou, Kaizheng Liu, Jinyu Pan i Zhongkai Wu. "M2b macrophages protect against doxorubicin induced cardiotoxicity via alternating autophagy in cardiomyocytes". PLOS ONE 18, nr 7 (27.07.2023): e0288422. http://dx.doi.org/10.1371/journal.pone.0288422.
Pełny tekst źródłaHamada, Juri, Altansarnai Baasanjav, Natsumi Ono, Kazuya Murata, Koichiro Kako, Junji Ishida i Akiyoshi Fukamizu. "Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity". American Journal of Physiology-Heart and Circulatory Physiology 308, nr 8 (15.04.2015): H931—H941. http://dx.doi.org/10.1152/ajpheart.00703.2013.
Pełny tekst źródłaWang, Yuewen, Xu Chao, Fiaz ud Din Ahmad, Hailong Shi, Hania Mehboob i Waseem Hassan. "Phoenix dactylifera Protects against Doxorubicin-Induced Cardiotoxicity and Nephrotoxicity". Cardiology Research and Practice 2019 (23.12.2019): 1–8. http://dx.doi.org/10.1155/2019/7395239.
Pełny tekst źródłaLi, Jun, Weiguo Wan, Tao Chen, Suiyang Tong, Xuejun Jiang i Wanli Liu. "miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice". BioMed Research International 2019 (4.07.2019): 1–11. http://dx.doi.org/10.1155/2019/1528278.
Pełny tekst źródłaGyongyosi, Alexandra, Nikolett Csaki, Agota Peto, Kitti Szoke, Ferenc Fenyvesi, Ildiko Bacskay i Istvan Lekli. "BGP-15 Protects against Doxorubicin-Induced Cell Toxicity via Enhanced Mitochondrial Function". International Journal of Molecular Sciences 24, nr 6 (9.03.2023): 5269. http://dx.doi.org/10.3390/ijms24065269.
Pełny tekst źródłaAl-Shabanah, Othman A., Abdulaziz M. Aleisa, Mohamed M. Hafez, Salim S. Al-Rejaie, Abdulaziz A. Al-Yahya, Saleh A. Bakheet, Mohamed M. Al-Harbi i Mohamed M. Sayed-Ahmed. "Desferrioxamine Attenuates Doxorubicin-Induced Acute Cardiotoxicity through TFG-β/Smad p53 Pathway in Rat Model". Oxidative Medicine and Cellular Longevity 2012 (2012): 1–7. http://dx.doi.org/10.1155/2012/619185.
Pełny tekst źródłaRäsänen, Markus, Joni Degerman, Tuuli A. Nissinen, Ilkka Miinalainen, Risto Kerkelä, Antti Siltanen, Janne T. Backman i in. "VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection". Proceedings of the National Academy of Sciences 113, nr 46 (31.10.2016): 13144–49. http://dx.doi.org/10.1073/pnas.1616168113.
Pełny tekst źródłaHaesen, Sibren, Eline Verghote, Ellen Heeren, Esther Wolfs, Dorien Deluyker i Virginie Bito. "Pyridoxamine Attenuates Doxorubicin-Induced Cardiomyopathy without Affecting Its Antitumor Effect on Rat Mammary Tumor Cells". Cells 13, nr 2 (9.01.2024): 120. http://dx.doi.org/10.3390/cells13020120.
Pełny tekst źródłaLaw, David, Mitchel A. Magrini, Jacob A. Siedlik, Joan Eckerson, Kristen M. Drescher i Eric C. Bredahl. "Creatine and Resistance Training: A Combined Approach to Attenuate Doxorubicin-Induced Cardiotoxicity". Nutrients 15, nr 18 (19.09.2023): 4048. http://dx.doi.org/10.3390/nu15184048.
Pełny tekst źródłaLegi, Ashiq, Emma Rodriguez, Thomas K. Eckols, Cyrus Mistry i Prema Robinson. "Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity". Cancers 13, nr 7 (6.04.2021): 1732. http://dx.doi.org/10.3390/cancers13071732.
Pełny tekst źródłaTao, Rong-Hua, Masato Kobayashi, Yuanzheng Yang i Eugenie S. Kleinerman. "Exercise Inhibits Doxorubicin-Induced Damage to Cardiac Vessels and Activation of Hippo/YAP-Mediated Apoptosis". Cancers 13, nr 11 (1.06.2021): 2740. http://dx.doi.org/10.3390/cancers13112740.
Pełny tekst źródłaZhang, Wen-Bin, Xin Lai i Xu-Feng Guo. "Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis". Oxidative Medicine and Cellular Longevity 2021 (26.01.2021): 1–14. http://dx.doi.org/10.1155/2021/8860883.
Pełny tekst źródłaRong, Jing, Lizhong Li, Li Jing, Haiqin Fang i Shuangqing Peng. "JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes". International Journal of Toxicology 35, nr 3 (2.11.2015): 317–26. http://dx.doi.org/10.1177/1091581815614261.
Pełny tekst źródłaAshour, Osama M., Ashraf B. Abdel-Naim, Hossam M. Abdallah, Ayman A. Nagy, Ahmed M. Mohamadin i Essam A. Abdel-Sattar. "Evaluation of the Potential Cardioprotective Activity of Some Saudi Plants against Doxorubicin Toxicity". Zeitschrift für Naturforschung C 67, nr 5-6 (1.06.2012): 297–307. http://dx.doi.org/10.1515/znc-2012-5-609.
Pełny tekst źródła